Algert Global LLC Chemo Centryx, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 15, 2022	SELL	$22.17 - $51.8 $918,281 - $2.15 Million	-41,420 Reduced 68.04%	19,455 $1.01 Million
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $717,926 - $1.29 Million	46,740 Added 330.67%	60,875 $1.51 Million
Q1 2022 May 16, 2022	BUY	$22.22 - $39.12 $314,079 - $552,961	14,135 New	14,135 $354,000
Q2 2020 Aug 12, 2020	SELL	$38.58 - $65.07 $295,870 - $499,021	-7,669 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$32.73 - $50.78 $251,006 - $389,431	7,669 New	7,669 $308,000
Q4 2019 Feb 18, 2020	SELL	$6.81 - $39.55 $234,672 - $1.36 Million	-34,460 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.47 - $8.96 $42,702 - $59,136	6,600 Added 23.69%	34,460 $234,000
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $127,425 - $227,709	15,334 Added 122.42%	27,860 $259,000
Q1 2019 May 01, 2019	SELL	$10.01 - $13.89 $652,101 - $904,864	-65,145 Reduced 83.87%	12,526 $174,000
Q4 2018 Feb 01, 2019	SELL	$9.15 - $12.26 $225,181 - $301,718	-24,610 Reduced 24.06%	77,671 $847,000
Q3 2018 Nov 14, 2018	BUY	$10.49 - $13.72 $68,153 - $89,138	6,497 Added 6.78%	102,281 $1.29 Million
Q2 2018 Aug 02, 2018	BUY	$10.62 - $13.98 $1.02 Million - $1.34 Million	95,784 New	95,784 $1.26 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.